plerixafor has been researched along with Diabetic Angiopathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fricker, S; Jiao, C; Schatteman, GC | 1 |
1 other study(ies) available for plerixafor and Diabetic Angiopathies
| Article | Year |
|---|---|
The chemokine (C-X-C motif) receptor 4 inhibitor AMD3100 accelerates blood flow restoration in diabetic mice.
Topics: Animals; Antigens, CD34; Benzylamines; Blood Flow Velocity; Cyclams; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Heterocyclic Compounds; Humans; Ischemia; Kinetics; Leukocyte Transfusion; Mice; Receptors, CXCR4 | 2006 |